Pilot Study Uses CRP, Calprotectin to Diagnose Pulmonary Exacerbations
Blood C-reactive protein (CRP) and calprotectin levels can reliably identify pulmonary exacerbations in cystic fibrosis (CF) patients, making them promising diagnostic biomarkers, a pilot study has found. Although further investigations are necessary to determine their clinical applicability, the researchers note that “a step-wise algorithm that…